J. Yau

Proteasome‐mediated cleavage of the Y‐box‐binding protein 1 is linked to DNA‐damage stress response

Alexey V. Sorokin, Anastasia A Selyutina, Maxim A. Skabkin et al. · The EMBO Journal · 2005 · 165 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Gemcitabine, dexamethasone and cisplatin is an active andnon-toxic chemotherapy regimen in relapsed or refractory Hodgkin’s disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group

Tara Baetz, Andrew R. Belch, Stephen Couban et al. · Annals of Oncology · 2003 · 160 citations · Full text

Medicine, Oncology, Pharmacology +17

Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial

Chih-Jian Lih, Robin Harrington, David Sims et al. · Journal of Molecular Diagnostics · 2017 · 157 citations · Full text

Medicine, Molecular Biology, Molecular Medicine +14

Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group.

David Warr, Paul Hoskins, Jean Latreille et al. · Journal of Clinical Oncology · 1994 · 116 citations

Medicine, Pharmacology, Pharmacotherapy +17

A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors

Rajyalakshmi Luthra, Keyur P. Patel, Mark J. Routbort et al. · Journal of Molecular Diagnostics · 2016 · 83 citations

Medicine, Molecular Genetics, Oncology +17